Advanced search
Combine gene, variant, phenotype, region and year filters
Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.
Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
Knowledge-base search
About your search
CD36 and lung cancer are reported together in 1 article.
Gene
CD36
- HGNC
- HGNC:1663
23articles
23mentions
1variants with confirmed gene link
Most co-reported phenotypes (articles)
dyslipidemia 4diabetes mellitus 3leukemia 2obesity 2Alzheimer disease 1breast cancer 1lung cancer 1metabolic syndrome 1
Reported variants (articles · ClinVar status)
Phenotype
Lung cancer
398articles
398mentions
12co-reported genes shown
Most co-reported genes (articles)
Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.
Publications
1 records shown · first 60Blood classical monocytes phenotype is not altered in primary non-small cell lung cancer.
PMID 25493244 | PMCID PMC4259935 | DOI 10.5306/wjco.v5.i5.1078 · World journal of clinical oncology · 2014 · 5 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | CD36 | “RESULTS: There were no significant difference in expression of M1 (HLA-DR) and/or M2 markers (CD163 and CD36) markers on classical monocytes in patients with NSCLC compared to non-cancer controls.” | 0.98 | hgnc_dict_v1 |
| phenotype | lung cancer | “Blood classical monocytes phenotype is not altered in primary non-small cell lung cancer.” | 0.98 | phenotype_alias_lexicon_v2 |
| gene | CD14 | “Flow cytometry was performed to investigate M1 and M2 phenotypes in peripheral monocytes (classical monocytes CD14+, CD45+ and CD16-) using conventional surface markers.” | 0.98 | hgnc_dict_v1 |
| gene | CD163 | “RESULTS: There were no significant difference in expression of M1 (HLA-DR) and/or M2 markers (CD163 and CD36) markers on classical monocytes in patients with NSCLC compared to non-cancer controls.” | 0.98 | hgnc_dict_v1 |